Integrative Health Technologies, Inc. (IHTI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2009 | 38.68 Thousand USD | 0.0% |
| 2006 | -37.18 Thousand USD | 32.6% |
| 2005 | -55.17 Thousand USD | 97.83% |
| 2004 | -2.53 Million USD | -291.94% |
| 2003 | -647.63 Thousand USD | -3496.17% |
| 2002 | -18 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2009 FY | 38.68 Thousand USD | 0.0% |
| 2007 Q2 | 151.81 Thousand USD | 1243.45% |
| 2007 Q1 | 11.3 Thousand USD | 100.75% |
| 2007 Q3 | 43.53 Thousand USD | -71.32% |
| 2006 Q1 | -255.12 Thousand USD | -138.88% |
| 2006 FY | -37.18 Thousand USD | 32.6% |
| 2006 Q4 | -1.5 Million USD | -901.4% |
| 2006 Q3 | 187.28 Thousand USD | -87.77% |
| 2006 Q2 | 1.53 Million USD | 700.44% |
| 2005 Q1 | -435.14 Thousand USD | 59.18% |
| 2005 FY | -55.17 Thousand USD | 97.83% |
| 2005 Q4 | 656.17 Thousand USD | 337.57% |
| 2005 Q3 | -276.2 Thousand USD | -1116.86% |
| 2005 Q2 | -22.69 Thousand USD | 94.78% |
| 2004 Q4 | -1.06 Million USD | -209.29% |
| 2004 Q2 | -343.48 Thousand USD | 56.19% |
| 2004 Q1 | -784.09 Thousand USD | -50.81% |
| 2004 FY | -2.53 Million USD | -291.94% |
| 2004 Q3 | -344.67 Thousand USD | -0.35% |
| 2003 Q2 | - USD | 100.0% |
| 2003 FY | -647.63 Thousand USD | -3496.17% |
| 2003 Q1 | -3582.00 USD | -14825.0% |
| 2003 Q4 | -519.93 Thousand USD | -318.89% |
| 2003 Q3 | -124.12 Thousand USD | 0.0% |
| 2002 FY | -18 Thousand USD | 0.0% |
| 2002 Q4 | -24.00 USD | 98.72% |
| 2002 Q3 | -1874.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 102.744% |
| Arrayit Corporation | -3.31 Million USD | 101.167% |
| Atlantic International Corp. | -5.62 Million USD | 100.687% |
| Biocept, Inc. | -32.08 Million USD | 100.121% |
| Bioqual, Inc. | 483.48 Thousand USD | 91.998% |
| CardioGenics Holdings Inc | -1.91 Million USD | 102.019% |
| DermTech, Inc. | -100.88 Million USD | 100.038% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 99.998% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 100.179% |
| iMD Companies, Inc. | -200.63 Thousand USD | 119.283% |
| IDenta Corp. | 14.64 Thousand USD | -164.197% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 95.176% |
| InVitro International | 1553.00 USD | -2391.243% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 100.45% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 166.577% |
| Medical Imaging Corp. | -3.02 Million USD | 101.28% |
| NovelStem International Corp. | -4.18 Million USD | 100.924% |
| Optigenex Inc. | -2.89 Million USD | 101.335% |
| PharmChem, Inc. | 845.1 Thousand USD | 95.422% |
| Proteome Sciences plc | -2.44 Million USD | 101.584% |
| Response Genetics, Inc | -20.18 Million USD | 100.192% |
| Rennova Health, Inc. | -3.29 Million USD | 101.175% |
| RushNet, Inc. | -607.02 Thousand USD | 106.374% |
| ScreenPro Security Inc. | -2.24 Million USD | 101.72% |
| Stella Diagnostics Inc. | -5.7 Million USD | 100.678% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 100.339% |
| Todos Medical Ltd. | -24.99 Million USD | 100.155% |